Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Evgen Pharma ( (GB:TCF) ) has shared an update.
TheraCryf PLC, a company involved in the pharmaceutical industry, has issued a notification regarding a significant change in its voting rights. The notification reveals that Simon Gibeon, based in London, has crossed a threshold of 3.3527% in voting rights as of March 11, 2025. This change could potentially impact the company’s governance and decision-making processes, reflecting a shift in shareholder influence.
More about Evgen Pharma
YTD Price Performance: -57.14%
Average Trading Volume: 2,247,055
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £4.79M
For detailed information about TCF stock, go to TipRanks’ Stock Analysis page.